4502 — Takeda Pharmaceutical Share News
0.000.00%
Last trade - 00:00Nvidia-backed Iambic Therapeutics tumbles below IPO price
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom (updated)
Focus: AI companies run virtual drug trials, aim to improve success of human studies
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Brief: FDA Directs Takeda To Add Boxed Warning To Adzynma Drug Label
Roche proposes former Takeda CEO for board seat
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Dr. Reddy's rises on India distribution deal for Takeda's dengue vaccine
Dr Reddy's signs India distribution deal for Takeda's Qdenga dengue vaccine (updated)
India's Dr Reddy's inks distribution agreement with Takeda for dengue vaccine in India
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Takeda Announces Planned Retirement Of President Of Research & Development Andy Plump Effective June 2027
Pharvaris' genetic disorder drug meets main goal in late-stage trial (updated)
Trump administration to announce drug pricing deals
US FDA approves Takeda, Protagonist's drug for rare blood cancer (updated)
US FDA approves Takeda, Protagonist's drug for rare blood cancer
Factbox: Pharma sector doubles down on AI amid hopes of slashing costs, timelines